Follow the Money to Medical Devices & Diagnostics
Spotlight on CartiHeal Ltd.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities.

CartiHeal Ltd. is a private company based in Israel that develops cell-free cartilage regeneration technology. It raised $18.3 million in the completion of a venture capital investment as reported in the PharmSource Lead Sheet on May 11, 2017.

Corporate Highlights

  • CartiHeal was founded in 2009
  • Corporate Headquarters: Kfar Saba, Israel

Sourcing Opportunities

  • CartiHeal plans to use the proceeds to fund the IDE clinical trial with its Agili-C implant:

Device: The Agili-C implant™
Development Phase: Pivotal studies
Medical Specialty: Orthopedics/Rehabilitation/Physical medicine
Purpose: Device – in vivo/Imaging device
Type: System/System accessory; Instrument/tool
Description: A MRI system that scans newborns within the NICU to diagnose a variety of conditions.

Device: The Stroke-dedicated MRI System™
Development Phase: Pre-feasibility studies
Medical Specialty: General Hospital
Purpose: Device – Therapeutic/Interventional
Type: Implant – Other
Description: A cell-free implant that regenerates hyaline cartilage and the underlying subchondral bone in a single-step procedure.

Previous Financings:

  • January 2016: $15 million in a completed venture capital investment
  • October 2013: $5 million in a completed venture capital investment

Medical Device & Diagnostics Pipeline1

Product Candidate Indication Medical Specialty Purpose Type Status
Agili-C Cartilage/
osteochondral defects
Orthopedics/
Rehabilitation/
Physical Medicine
Device – Therapeutic/
Interventional
Implant – Other Pivotal studies

Regulatory Approvals and Clearances

Product Candidate Region Approval/Clearance Year of Approval or Clearance
Agili-C US IDE 2016
Agili-C EU CE Mark N/A

1Source: PharmSource Lead Sheet

Contact Information

CartiHeal Ltd. Key Officers
Atir Yeda 17, 4th Floor Nir Altschuler, CEO
Kfar Saba, 4464313 Israel Yulia Chaikin, PhD, Lead Scientist
Phone: + 972 9 881 0400 Dvora Darky, Manager, Clinical Trials
Fax: + 972 9 881 0401 Stuart Bernstein, Director, Marketing
Web: www.cartiheal.com Amir Goren, VP, Operations

Related posts:
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Aspect Imaging, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on RenalGuard Solutions, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Flow Forward Medical, LLC

Scotty is a Research Analyst at PharmSource. He holds a BS degree in Biology from George Mason University and an MPH degree from Eastern Virginia Medical School. He’s experienced in data collection, analysis and management, and has done laboratory analysis and safety program development.

More posts by Scotty Chung-Siu